Recruiting NCT06655012

Salmeterol Effect on Exercise Performance

No phase Interventional Healthy

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied: The protocol lists: Salmeterol, Placebo.
Who it may be relevant to: Registry conditions: Healthy. Basic parameters: 18 years — 40 years · All.
What needs checking: Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place: Denmark
Next step: Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Official title

The Muscle Anabolic Response to β2-adrenergic Stimulation

The purpose of the project is to investigate the muscle anabolic response to acute beta2-adrenergic stimulation in young healthy men and women.

Drug Salmeterol
Participants are administered 200 µg salmeterol (8 puffs) from a MDI device
Drug Placebo
Participants are administered placebo (8 puffs) from a MDI device

Power output during sprint testing [Time frame: Through study completion, an average on 2 weeks]

Secondary outcome measures (1)

Power output during time trial [Time frame: Through study completion, an average on 2 weeks]

Active smoker currently or within the past 5 years
Regular intake of medication deemed by the responsible study physician to affect the test parameters (hormonal contraception is accepted for women)
Chronic or acute illness deemed by the responsible study physician to affect the test parameters
Deviation from the study protocol
Lean mass index >21 kg/m²
Pregnancy
Smoker
Blood donation during the past 3 months

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Denmark · 1 center

NCT: NCT06655012 · SALM_acute